Drugs Made In America Acquisition (DMAA) Total Current Liabilities (2024 - 2025)
Drugs Made In America Acquisition's (DMAA) quarterly Total Current Liabilities came in at $376172.0 in Q4 2025, down 52.72% YoY from $795669.0 in Q4 2024, and down 17.62% on a QoQ basis from $456611.0 in Q3 2025.
Drugs Made In America Acquisition (DMAA) Total Current Liabilities (2024 - 2025) Analysis & Trends
Drugs Made In America Acquisition (DMAA) has 2 years of Total Current Liabilities data on file, last reported at $376172.0 in Q4 2025.
- Quarterly Total Current Liabilities fell 52.72% year-over-year to $376172.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $376172.0 (down 52.72% YoY) and the FY2025 annual result came in at $376172.0, down 52.72% from the prior year.
- Total Current Liabilities slipped to $376172.0 in Q4 2025, from $456611.0 in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $795669.0 in Q4 2024 to a low of $301441.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oxley Bridge Acquisition | 585.76 Mn | 585.76 Mn | - | 146,923.00 |
| 2 | Launch Two Acquisition | 557.86 Mn | 557.86 Mn | - | 281,435.00 |
| 3 | Drugs Made In America Acquisition | 507.00 Mn | 507.00 Mn | - | 644,574.00 |
| 4 | Cantor Equity Partners IV | 468.00 Mn | 468.00 Mn | - | - |
| 5 | GP-Act III Acquisition | 401.06 Mn | 401.06 Mn | - | 2.38 Mn |
| 6 | Aldel Financial | 397.49 Mn | 397.49 Mn | - | 20,057.00 |
| 7 | Republic Digital Acquisition | 389.25 Mn | 388.51 Mn | - | 38,850.00 |
| 8 | Gores Holdings X | 385.06 Mn | 384.87 Mn | - | 3.69 Mn |
| 9 | Agriculture & Natural Solutions Acquisition | 377.29 Mn | 377.04 Mn | - | 22.16 Mn |
| 10 | Drugs Made In America Acquisition | 215.82 Mn | 215.82 Mn | - | 2.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 376,172.00 |
| Sep 30, 2025 | 456,611.00 |
| Jun 30, 2025 | 301,441.00 |
| Mar 31, 2025 | 347,369.00 |
| Dec 31, 2024 | 795,669.00 |